|

ASC30 tablets A1 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 3: 1

Top Sponsors

  • Ascletis Pharma (China) Co., Limited1

Indications

  • Chronic Weight Management1
  • Type 2 Diabetes Mellitus1
  • Diabetes1
  • Overweight1
  • Obesity1

Birmingham, Alabama1 trial

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

AURORA-2 Clinical Site

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.